ES8801267A1 - Procedimiento para preparar derivados de isoquinolinona - Google Patents

Procedimiento para preparar derivados de isoquinolinona

Info

Publication number
ES8801267A1
ES8801267A1 ES557171A ES557171A ES8801267A1 ES 8801267 A1 ES8801267 A1 ES 8801267A1 ES 557171 A ES557171 A ES 557171A ES 557171 A ES557171 A ES 557171A ES 8801267 A1 ES8801267 A1 ES 8801267A1
Authority
ES
Spain
Prior art keywords
pyrimido
derivatives
isoquinolin
isoquinoline
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557171A
Other languages
English (en)
Other versions
ES557171A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES557171A0 publication Critical patent/ES557171A0/es
Publication of ES8801267A1 publication Critical patent/ES8801267A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE ISOQUINOLINONA, DE FORMULA GENERAL (I), Y DE SUS SALES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN HACER REACCIONAR UN DERIVADO DE PIRIMIDO 2,1-AISOQUINOLIN-4-ONA, DE FORMULA GENERAL (II), EN LA QUE Z ES UN GRUPO ESTER DISOCIABLE, CON UNA N1,N-DIALQUILALQUENDIAMINA, DE FORMULA GENERAL (III), EN LA QUE N ES UN ENTERO DE 1 A 4; Y R1 Y R2 SON INDEPENDIENTEMENTE, HIDROGENO O ALQUILO INFERIOR, EN PRESENCIA DE UN DISOLVENTE ORGANICO Y A LA TEMPERATURA DE REFLUJO DE LA MEZCLA DE REACCION. DE APLICACION COMO AGENTES ANORECTICOS UTILIZADOS PARA FINES TERAPEUTICOS.
ES557171A 1984-06-27 1986-10-31 Procedimiento para preparar derivados de isoquinolinona Expired ES8801267A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/625,061 US4661592A (en) 1984-06-27 1984-06-27 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives

Publications (2)

Publication Number Publication Date
ES557171A0 ES557171A0 (es) 1988-01-01
ES8801267A1 true ES8801267A1 (es) 1988-01-01

Family

ID=24504413

Family Applications (2)

Application Number Title Priority Date Filing Date
ES544581A Expired ES8703872A1 (es) 1984-06-27 1985-06-26 Procedimiento para preparar derivados de isoquinolina.
ES557171A Expired ES8801267A1 (es) 1984-06-27 1986-10-31 Procedimiento para preparar derivados de isoquinolinona

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES544581A Expired ES8703872A1 (es) 1984-06-27 1985-06-26 Procedimiento para preparar derivados de isoquinolina.

Country Status (7)

Country Link
US (1) US4661592A (es)
EP (1) EP0166439B1 (es)
JP (1) JPS6124593A (es)
AU (1) AU4417985A (es)
DE (1) DE3577559D1 (es)
ES (2) ES8703872A1 (es)
ZA (1) ZA854877B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162019C (no) * 1983-11-23 1989-10-25 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater.
JPH0619904Y2 (ja) * 1988-09-16 1994-05-25 株式会社クボタ 管継手
JPH0726632Y2 (ja) * 1990-09-28 1995-06-14 徳厚 小島 管継手
WO2008148074A2 (en) * 2007-05-24 2008-12-04 Research Foundation Of State University Of New York Inhibitors of mtor and methods of treatment using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU168014B (es) * 1973-03-30 1976-02-28
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
US4348396A (en) * 1978-01-23 1982-09-07 Hoffmann-La Roche Inc. Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them
NO162019C (no) * 1983-11-23 1989-10-25 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoiskinolinderivater.

Also Published As

Publication number Publication date
EP0166439A3 (en) 1987-05-20
ES8703872A1 (es) 1987-03-01
JPS6124593A (ja) 1986-02-03
EP0166439A2 (en) 1986-01-02
ZA854877B (en) 1986-08-27
DE3577559D1 (de) 1990-06-13
AU4417985A (en) 1986-01-02
US4661592A (en) 1987-04-28
ES557171A0 (es) 1988-01-01
ES544581A0 (es) 1987-03-01
EP0166439B1 (en) 1990-05-09

Similar Documents

Publication Publication Date Title
MY101791A (en) New benzimidazole derivatives
PT81007A (en) Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same
MY101784A (en) Novel pharmacological compounds
IL84944A (en) Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
IL76405A0 (en) 1,3-diacyl-2-oxyindole derivatives,their preparation and pharmaceutical compositions containing them
IL112622A0 (en) Camptothecin derivatives, their preparation and pharmaceutical compositions containing them
IL86798A0 (en) 2,2-dimethylchroman-3-ol derivatives,their preparation and pharmaceutical compositions containing them
IL85312A0 (en) Improving the stability of pharmaceutical compositions
AU568920B2 (en) Pharmaceutical compositions of 3,4-dihydroisoquinolinium salts
IL75943A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL85290A0 (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation and pharmaceutical compositions containing same
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
IL88002A0 (en) 2,2-dimethylchromene derivatives,their preparation and pharmaceutical compositions containing them
IL85992A0 (en) Dihydropyridinamides,their preparation and pharmaceutical compositions containing them
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
NZ211960A (en) Benz(5,6)isoindolo(2,1-b)isoquinoline-8,13-dione derivatives and pharmaceutical compositions
ES8703872A1 (es) Procedimiento para preparar derivados de isoquinolina.
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
IL90231A0 (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives,their preparation and pharmaceutical compositions containing them
IL75603A0 (en) 1,3-dioxanylheptenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL90652A (en) 8,9-annelated-b-carboline and -3,4-dihydro-b- carboline derivatives, their preparation and pharmaceutical compositions containing them
NZ220541A (en) Tetrazole derivatives and pharmaceutical compositions